Does TALAZOPARIB Cause Decreased appetite? 23 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Decreased appetite have been filed in association with TALAZOPARIB (Talzenna). This represents 1.6% of all adverse event reports for TALAZOPARIB.
23
Reports of Decreased appetite with TALAZOPARIB
1.6%
of all TALAZOPARIB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Decreased appetite From TALAZOPARIB?
Of the 23 reports, 1 (4.3%) resulted in death, 11 (47.8%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for TALAZOPARIB.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which TALAZOPARIB Alternatives Have Lower Decreased appetite Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS